Table 1 Patient characteristics
Variable | n | Percent |
|---|---|---|
Median Age (years) | 60.7 (range 21–92) | |
Median Tumor Volume (cc) | 8.7 (range 0.67 – 62.2) | |
Gender: | ||
Male | 58 | 25.9% |
Female | 166 | 74.1% |
Location: | ||
Cavernous sinus | 66 | 29.5% |
Parasellar | 9 | 4.0% |
Sphenoid/clinoid | 65 | 29.0% |
CPA | 32 | 14.3% |
Clivus | 7 | 3.1% |
Sellar/suprasellar | 16 | 7.1% |
Planum | 15 | 6.7% |
Craniocervical | 13 | 5.8% |
Other | 1 | 0.4% |
Laterality | ||
Left | 95 | 42.4% |
Right | 84 | 37.5% |
Midline/Bilateral | 44 | 19.6% |
Unknown | 1 | 0.4% |
Symptoms at time of Radiation | ||
Symptomatic | 205 | 91.5% |
Asymptomatic | 19 | 8.6% |
Intensity Modulate Radiation Therapy | ||
Yes | 41 | 18.3% |
No | 183 | 81.7% |
Neurofibramatosis-2 | 3 | 1.4% |
Treatment Group*: | ||
Radiation only | 115 | 51.3% |
Adjuvant radiation | 40 | 17.9% |
Progression after surgery | 58 | 25.9% |
Re-irradiation | 11 | 4.9% |
Pathology | ||
No pathologic diagnosis | 112 | 50.0% |
WHO grade I | 108 | 48.2% |
WHO grade II | 4 | 1.8% |
Dose | ||
> 52.5 Gy | 125 | 55.8% |
<= 52.2 Gy | 99 | 44.2% |